Home » Topics » Disease categories and therapies » Musculoskeletal

Musculoskeletal
RSS

New NSAID from Maruho and Toyama (M-5011) compares favorably with known compounds

Feb. 16, 1998

Pharmacokinetic/pharmacodynamic characterization of CP-105696 in volunteers

Feb. 13, 1998

Biphenylsulfonamides with MMP-inhibitory effects developed at Warner-Lambert

Feb. 13, 1998

Inhibitors of secretory PLA2 produced by Streptomyces violaceusniger

Feb. 12, 1998

New antiinflammatory agents prepared by Brazilian academics

Feb. 11, 1998

Idec evaluates humanized anti-gp39 antibody in phase I

Feb. 11, 1998

FDA approves new dosage strength of Lodine XL

Feb. 10, 1998

Positive preclinical results reported for IPL-423

Feb. 10, 1998

Several related series of MMP inhibitors claimed by Bayer

Feb. 9, 1998

Yeda patents IFN-alpha/beta receptor-neutralizing antibodies

Feb. 3, 1998

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for March 13, 2026.
Brain’s hidden tau-clearing pathway uncovered
BioWorld Science
Researchers at INSERM and collaborators have identified hypothalamic tanycytes as mediators of tau clearance and shown that their structural and genetic...
News in brief
BioWorld Asia
BioWorld Asia briefs for March 10, 2026
MSD synthesizes α-synuclein PET agents
BioWorld Science
Merck Sharp & Dohme LLC (MSD) has prepared and tested new positron emission tomography (PET) agents for binding and imaging α-synuclein (SNCA) for the diagnosis...
Keros reports beneficial effects of RKER-065 in ALS model
BioWorld Science
Keros Therapeutics Inc. has presented data regarding their activin receptor ligand trap, RKER-065, for the inhibition of the activin/myostatin signaling axis.